Literature DB >> 17416849

On the TRAIL toward death receptor-based cancer therapeutics.

Thomas F Gajewski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416849     DOI: 10.1200/JCO.2006.09.9804

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy.

Authors:  Fei Yi; Nicholas Frazzette; Anthony C Cruz; Christopher A Klebanoff; Richard M Siegel
Journal:  Trends Mol Med       Date:  2018-06-04       Impact factor: 11.951

2.  Macrophage Elastase Induces TRAIL-mediated Tumor Cell Death through Its Carboxy-Terminal Domain.

Authors:  Nadine Dandachi; Neil J Kelly; John P Wood; Christine L Burton; Josiah E Radder; Adriana S Leme; Alyssa D Gregory; Steven D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

3.  Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.

Authors:  Motoo Nagane; Saki Shimizu; Eiji Mori; Shiro Kataoka; Yoshiaki Shiokawa
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

Review 4.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

5.  Altered regulation of extrinsic apoptosis pathway in HCV-infected HCC cells enhances susceptibility to mapatumumab-induced apoptosis.

Authors:  Xiaozhen Zhang; Astrid C Frank; Christine M Gille; Marybeth Daucher; Juraj Kabat; Steven Becker; Richard A Lempicki; Karoll J Cortez; Michael A Polis; G Mani Subramanian; Shyam Kottilil
Journal:  Hepatol Res       Date:  2009-09-25       Impact factor: 4.288

Review 6.  TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.

Authors:  Andrew Thorburn; Kian Behbakht; Heide Ford
Journal:  Drug Resist Updat       Date:  2008-04-18       Impact factor: 18.500

Review 7.  Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).

Authors:  Giulia Grazia; Ilaria Penna; Valentina Perotti; Andrea Anichini; Elena Tassi
Journal:  Int J Oncol       Date:  2014-06-10       Impact factor: 5.650

8.  DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.

Authors:  Anita C Bellail; Margaret C L Tse; Jin H Song; Surasak Phuphanich; Jeffrey J Olson; Shi Yong Sun; Chunhai Hao
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.